Literature DB >> 22139198

Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis.

Chaoying Hu1, Liu Qian, Yi Miao, Qiuyu Huang, Ping Miao, Ping Wang, Qiwen Yu, Hong Nie, Jiying Zhang, Dongyi He, Rong Xu, Xuehua Chen, Bingya Liu, Dongqing Zhang.   

Abstract

Rheumatoid arthritis is an autoimmune disease that primarily affects the limbs, but the pathogenic mechanism remains unclear. γδ T cells, a T-cell subpopulation, are characterized by multiple biological functions and associated with a variety of diseases. This study investigated the antigen-presenting effects of γδ T cells and their relationship with rheumatoid arthritis development. We found that Vγ9Vδ2 T cells (the predominant subtype of γδ T cells in peripheral blood) were activated by isopentenyl pyrophosphate to continuously proliferate and differentiate into effector memory cells. The effector memory Vγ9Vδ2 T cells exhibited phenotypic characteristics of specific antigen-presenting cells, including high HLA-DR and CD80/86 expression. These Vγ9Vδ2 T cells could present soluble antigens and synthetic peptides to CD4(+) T cells. Vγ9Vδ2 T cells with different phenotypes showed different cytokine secretion patterns. Effector memory Vγ9Vδ2 T cells simultaneously secreted not only interferon (IFN)-γ but also IL-17. The peripheral blood and joint synovial fluid from RA patients contained numerous heterogeneous γδ T cells that were predominantly effector memory Vγ9Vδ2 T cells with the ability to secrete inflammatory factors. We also found that γδ T cells had a similar antigen-presenting capability to B cells. These results suggest that during the development of rheumatoid arthritis, γδ T cells can aggravate immune dysfunction and produce abnormal immune damage by secreting cytokines and inducing inflammatory cells to participate in synergistic inflammatory responses. Furthermore, γδ T cells can behave similarly to B cells to present viral peptides and autoantigen peptides to CD4(+) T cells, thus sustaining CD4(+) T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139198      PMCID: PMC4012843          DOI: 10.1038/cmi.2011.50

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  34 in total

Review 1.  The function of gammadelta T cells in innate immunity.

Authors:  Willi K Born; Christopher L Reardon; Rebecca L O'Brien
Journal:  Curr Opin Immunol       Date:  2005-12-06       Impact factor: 7.486

2.  In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation.

Authors:  V Ferlazzo; C Sferrazza; N Caccamo; G Di Fede; G Di Lorenzo; M D'Asaro; S Meraviglia; F Dieli; G Rini; A Salerno
Journal:  Int J Immunopathol Pharmacol       Date:  2006 Apr-Jun       Impact factor: 3.219

3.  Mesenteric lymph node Tgammadelta cells induced by gastrectomy in mice suppress cell-mediated immune response in vitro via released TGF-beta.

Authors:  Andrzej Gryglewski; Pawel Majcher; Krzysztof Bryniarski; Stanislaw Konturek; Maria Ptak; Wlodzimierz Ptak; Marian Szczepanik
Journal:  J Surg Res       Date:  2007-07-05       Impact factor: 2.192

Review 4.  gammadelta T cells: an important source of IL-17.

Authors:  Christina L Roark; Philip L Simonian; Andrew P Fontenot; Willi K Born; Rebecca L O'Brien
Journal:  Curr Opin Immunol       Date:  2008-04-23       Impact factor: 7.486

Review 5.  Perspectives of gammadelta T cells in tumor immunology.

Authors:  Dieter Kabelitz; Daniela Wesch; Wei He
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

6.  Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis.

Authors:  T Takeda; Y Mizugaki; L Matsubara; S Imai; T Koike; K Takada
Journal:  Arthritis Rheum       Date:  2000-06

7.  Decreased expression of FcgammaRIII (CD16) by gammadelta T cells in patients with rheumatoid arthritis.

Authors:  M D Bodman-Smith; A Anand; V Durand; P Y Youinou; P M Lydyard
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

8.  Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.

Authors:  Yoshinaga Ito; Takashi Usui; Shio Kobayashi; Mikiko Iguchi-Hashimoto; Hiromu Ito; Hiroyuki Yoshitomi; Takashi Nakamura; Masakazu Shimizu; Daisuke Kawabata; Naoichiro Yukawa; Motomu Hashimoto; Noriko Sakaguchi; Shimon Sakaguchi; Hajime Yoshifuji; Takaki Nojima; Koichiro Ohmura; Takao Fujii; Tsuneyo Mimori
Journal:  Arthritis Rheum       Date:  2009-08

9.  Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans.

Authors:  Bernadette Pöllinger; Tobias Junt; Barbara Metzler; Ulrich A Walker; Alan Tyndall; Cyril Allard; Serkan Bay; Roland Keller; Friedrich Raulf; Franco Di Padova; Terrence O'Reilly; Nicole J Horwood; Dhavalkumar D Patel; Amanda Littlewood-Evans
Journal:  J Immunol       Date:  2011-01-07       Impact factor: 5.422

10.  Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites.

Authors:  Francesco Dieli; Fabrizio Poccia; Martin Lipp; Guido Sireci; Nadia Caccamo; Caterina Di Sano; Alfredo Salerno
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  22 in total

Review 1.  IL-17 and limits of success.

Authors:  Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell Immunol       Date:  2018-09-17       Impact factor: 4.868

2.  T helper type 1 polarizing γδ T cells and Scavenger receptors contribute to the pathogenesis of Pemphigus vulgaris.

Authors:  Dayasagar Das; Vivek Anand; Sujay Khandpur; Vinod K Sharma; Alpana Sharma
Journal:  Immunology       Date:  2017-10-12       Impact factor: 7.397

Review 3.  γδ T Cells and dendritic cells in refractory Lyme arthritis.

Authors:  Ali Divan; Ralph C Budd; Richard P Tobin; M Karen Newell-Rogers
Journal:  J Leukoc Biol       Date:  2015-01-20       Impact factor: 4.962

4.  Immune-mediated syndromes following intravenous bisphosphonate therapy.

Authors:  Noa Markovits; Ronen Loebstein; Ilan Bank
Journal:  Inflammopharmacology       Date:  2017-05-31       Impact factor: 4.473

5.  Vγ9Vδ2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates.

Authors:  Jinrong Li; Hong Li; Huawei Mao; Meixing Yu; Ting Feng; Fan Yang; Yingying Fan; Qiao Lu; Chongyang Shen; Zhongwei Yin; Wenwei Tu; Meng Mao
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

6.  Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells.

Authors:  Hong Li; Zheng Xiang; Ting Feng; Jinrong Li; Yinping Liu; Yingying Fan; Qiao Lu; Zhongwei Yin; Meixing Yu; Chongyang Shen; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

Review 7.  Roles of γδ T cells in the pathogenesis of autoimmune diseases.

Authors:  Dinglei Su; Minning Shen; Xia Li; Lingyun Sun
Journal:  Clin Dev Immunol       Date:  2013-02-28

Review 8.  γδ T cells and their potential for immunotherapy.

Authors:  Yan-Ling Wu; Yan-Ping Ding; Yoshimasa Tanaka; Li-Wen Shen; Chuan-He Wei; Nagahiro Minato; Wen Zhang
Journal:  Int J Biol Sci       Date:  2014-01-10       Impact factor: 6.580

9.  Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis.

Authors:  Agneta J Laurent; Niels Bindslev; Björn Johansson; Louise Berg
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

10.  Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions.

Authors:  Mohd Wajid A Khan; Stuart M Curbishley; Hung-Chang Chen; Andrew D Thomas; Hanspeter Pircher; Domenico Mavilio; Neil M Steven; Matthias Eberl; Bernhard Moser
Journal:  Front Immunol       Date:  2014-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.